from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1963c/mce3R

LFCtreatmentdescriptionclass of inhibitor

2.147

Amikacinug/mL Amikacintranslation

1.717

Cap5-10ug/mL Capreomycintranslation

2.293

Rox10-50 ug/mL Roxithromycintranslation

0.688

SM2-5 ug/mL Streptomycintranslation

2.972

Tet5-10 ug/mL Tetracyclinetranslation

0.510

Rif0.2-5ug/mL Rifampicintranscription

0.247

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.847

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.793

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.610

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.369

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.419

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.309

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.399

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.113

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.548

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.633

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.775

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.173

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.740

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.775

KCN5-20 ug/mL Potassium cyaniderespiration

-1.651

NaN30.2-2 mM Sodium aziderespiration

-0.102

Nigericin50 uM Nigericinrespiration

0.052

TRC10-150 ug/mL Triclosanrespiration

-0.200

TRZ10-25 ug/mL Thioridazinerespiration

2.458

Valinomycin0.5-10 uM Valinomycinrespiration

-2.304

ZnSO42 mM ZnSO4respiration

-1.152

menadione6-10 ug/mL Menadionerespiration

-0.202

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.062

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.088

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.091

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.502

NRP_1Non-replicating persistence stage 1dosRassociated

-0.484

Amp0.2mg/mL AmpicillincellWall

0.266

Cephalexin20-100 ug/mL CephalexincellWall

0.004

Cerulenin0.32-5 ug/mL CerulenincellWall

0.277

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.101

EMB10-20 ug/mL EthambutolcellWall

-0.309

Eta12-40 ug/mL EthionamidecellWall

-0.334

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.099

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.079

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.123

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.108

BZA0.12 mg/mL BenzamidearomaticAmides

-0.224

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.286

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.451

H2O24 mM hydrogen peroxideDNAdamaging

-0.577

Levo10 ug/mL LevofloxacinDNAdamaging

-0.520

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.444

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.475

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.550

UVUV-irradiationDNAdamaging

0.280

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.324

Antimycin12.5-50 ug/mL Antimycin A?

0.120

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.283

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.505

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.341

PA8240.2-2 ug/mL PA-824?

0.149

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.518

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.120

Verapamil50 uM Verapamil?

-0.529

mercaptoethanol2 mM 2-Mercaptoethanol?

0.028

methoxatin10-20 ug/mL Methoxatin?